SOPHARMA AD: INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 June 2017

opublikowano: 2017-07-31 13:19

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikĂłw:
SFARM_Q2_individual_financial_statements.zip (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		56	/	2017
	Date of issue:		2017-07-31
	Short name of the issuer
	SOPHARMA AD
	Subject
	INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 June 2017
	Official market - legal basis
	art. 56. 1. 2 of Act on Public Offering.
	Unofficial market - legal basis
	Contents of the report:
	INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 June 2017 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration of the responsible directors 6. Insiders' information 7. Additional information 8. List of insider information under Art. 7 of Regulation (EU) 596/2014
	Annexes
	File				Description
	SFARM_Q2_individual_financial_statements.zipSFARM_Q2_individual_financial_statements.zip				INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 June 2017

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2017-07-31	Ognian Donev	Executive director